|
|
40
|
|
|
4181BH
|
|
|
BEMABIX 25MG/ML INJ (ABB/PHA) BEVACIZUMAB (C)
|
|
|
|
|
|
4ML VIAL
|
|
|
C
|
|
|
856.27
|
|
|
|
|
|
2022-04-01
|
|
|
2023-04-18
|
|
|
Delete from contract
|
|
|
2023-03-07
|